Abstract: Osteochondrosis (OC(D)) is a juvenile osteo-articular disorder affecting several mammalian species. In horses, OC(D) is considered as a multifactorial disease and has been described as a focal disruption of endochondral ossification leading to the development of osteoarticular lesions. Nevertheless, OC(D) physiopathology is poorly understood. Affected horses may present joint swelling, stiffness and lameness. Thus, OC(D) is a major concern for the equine industry. Our study was designed as an integrative approach using omics technologies for the identification of constitutive defects in epiphyseal cartilage and/or subchondral bone associated with the development of primary lesions to further understand OC(D) pathology. This study compared samples from non-affected joints (hence lesion-free) from OC(D)-affected foals (n = 5, considered predisposed samples) with samples from OC-free foals (n = 5) considered as control samples. Consequently, results are not confounded by changes associated with the evolution of the lesion, but focus on altered constitutive molecular mechanisms. Comparative proteomics and micro computed tomography analyses were performed on predisposed and OC-free bone and cartilage samples. Metabolomics was also performed on synovial fluid from OC-free, OC(D)-affected and predisposed joints. Results: Two lesion subtypes were identified: OCD (lesion with fragment) and OC (osteochondral defects). Modulated proteins were identified using omics technologies (2-DE proteomics) in cartilage and bone from affected foals compare to OC-free foals. These were associated with cellular processes including cell cycle, energy production, cell signaling and adhesion as well as tissue-specific processes such as chondrocyte maturation, extracellular matrix and mineral metabolism. Of these, five had already been identified in synovial fluid of OC-affected foals: ACTG1 (actin, gamma 1), albumin, haptoglobin, FBG (fibrinogen beta chain) and C4BPA (complement component 4 binding protein, alpha). Conclusions: This study suggests that OCD lesions may result from a cartilage defect whereas OC lesions may be triggered by both bone and cartilage defects, suggesting that different molecular mechanisms responsible for the equine osteochondrosis lesion subtypes and predisposition could be due to a defect in both bone and cartilage. This study will contribute to refining the definition of OC(D) lesions and may improve diagnosis and development of therapies for horses and other species, including humans.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research article discusses how the use of omics technologies have increased understanding of equine osteochondrosis. It progresses to explain how these technologies were used to identify altered molecular mechanisms within bone and cartilage that could potentially lead to the development of the disease.
Research Objective
The study aimed to identify the elements in bone and cartilage that could potentially lead to the onset of equine osteochondrosis (OC(D)), a juvenile osteo-articular disorder that affects horses. The disorder is a significant concern for horse breeders and owners because it can lead to joint stiffness, limb lameness, and swelling.
Methodology
The study compared the joints of foals displaying OC(D) symptoms with those of foal samples not affected by the disease. To do this, the researchers used omics technologies to study and compare the samples. Omics technologies refer to the different types of biological analysis approaches in genomics, proteomics, metabolomics and others that seek comprehensive and holistic views of the structures, functions, and dynamics of an organism or populations of organisms.
These comparisons were done in a way that did not factor in changes associated with the evolution of the lesion but focused on altered molecular mechanisms that might have led to the onset of the disease.
They performed comparative proteomics and micro computed tomography analyses on healthy and predisposed bone and cartilage samples. They also performed metabolomics on synovial fluid, which is a viscous liquid found in small quantities in the cavities of the synovial joints.
Results
Through their research, the team turned up two OC(D) subtypes: Osteochondrosis dissecans (OCD) – which left a lesion with fragment- and osteochondral defects (OC), through the use of omics technologies they were also able to identify proteins that were modulated in cartilage and bone samples from foals affected by OC(D) in comparison to samples not affected by the disease.
They established that the modulated proteins were associated with cellular processes including energy production, cell signalling, cell cycle, tissue-specific processes such as mineral metabolism, extracellular matrix and chondrocyte maturation.
Furthermore, five of these proteins, which included fibrinogen beta chain (FBG), albumin, actin, gamma 1 (ACTG1), complement component 4 binding protein, alpha (C4BPA), and haptoglobin, had already been identified in synovial fluid of OC(D)-affected foals.
Conclusions
The study suggested that OC(D) lesions likely result from a defect in cartilage or bone, and that different molecular mechanisms could be responsible for the specific types of equine osteochondrosis lesions found.
The researchers believe this study will help improve the definition of OC(D) lesions and potentially contribute to the development of therapeutic solutions to treat the disorder in horses and possibly even humans.
Cite This Article
APA
Desjardin C, Riviere J, Vaiman A, Morgenthaler C, Diribarne M, Zivy M, Robert C, Le Moyec L, Wimel L, Lepage O, Jacques C, Cribiu E, Schibler L.
(2014).
Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis.
BMC Genomics, 15(1), 947.
https://doi.org/10.1186/1471-2164-15-947
Ytrehus B, Ekman S, Carlson CS, Teige J, Reinholt FP. Focal changes in blood supply during normal epiphyseal growth are central in the pathogenesis of osteochondrosis in pigs.. Bone 2004 Dec;35(6):1294-306.
Muir H. The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules.. Bioessays 1995 Dec;17(12):1039-48.
Guilak F, Fermor B, Keefe FJ, Kraus VB, Olson SA, Pisetsky DS, Setton LA, Weinberg JB. The role of biomechanics and inflammation in cartilage injury and repair.. Clin Orthop Relat Res 2004 Jun;(423):17-26.
Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics.. Anal Chem 2006 Jul 1;78(13):4281-90.
Donabedian M, Fleurance G, Perona G, Robert C, Lepage O, Trillaud-Geyl C, Leger S, Ricard A, Bergero D, Martin-Rosset W. Effect of fast vs. moderate growth rate related to nutrient intake on developmental orthopaedic disease in the horse. Anim Res 2006;55:471–486.
Alexopoulos LG, Youn I, Bonaldo P, Guilak F. Developmental and osteoarthritic changes in Col6a1-knockout mice: biomechanics of type VI collagen in the cartilage pericellular matrix.. Arthritis Rheum 2009 Mar;60(3):771-9.
Skagen PS, Horn T, Kruse HA, Staergaard B, Rapport MM, Nicolaisen T. Osteochondritis dissecans (OCD), an endoplasmic reticulum storage disease?: a morphological and molecular study of OCD fragments.. Scand J Med Sci Sports 2011 Dec;21(6):e17-33.
Wang X, Eno CO, Altman BJ, Zhu Y, Zhao G, Olberding KE, Rathmell JC, Li C. ER stress modulates cellular metabolism.. Biochem J 2011 Apr 1;435(1):285-96.
Naughton D, Whelan M, Smith EC, Williams R, Blake DR, Grootveld M. An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy.. FEBS Lett 1993 Feb 8;317(1-2):135-8.
Xu L, Flahiff CM, Waldman BA, Wu D, Olsen BR, Setton LA, Li Y. Osteoarthritis-like changes and decreased mechanical function of articular cartilage in the joints of mice with the chondrodysplasia gene (cho).. Arthritis Rheum 2003 Sep;48(9):2509-18.
Yoshimi M, Miyaishi O, Nakamura S, Shirasawa S, Kamochi H, Miyatani S, Ikawa Y, Shinomura T. Identification of genes preferentially expressed in articular cartilage by suppression subtractive hybridization.. J Med Dent Sci 2005 Dec;52(4):203-11.
Woods A, Wang G, Beier F. Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions.. J Cell Physiol 2007 Oct;213(1):1-8.
Gohda T, Makita Y, Shike T, Tanimoto M, Funabiki K, Horikoshi S, Tomino Y. Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a Type 2 diabetes model: is Zn-alpha2 glycoprotein-1 a candidate gene for obesity?. Diabetes 2003 Aug;52(8):2175-81.
Zhang B, Guo YK, Li S, Zhang LZ, Lan XY, Hu SR, Chen H. Genotype and haplotype analysis of the AZGP1 gene in cattle.. Mol Biol Rep 2012 Dec;39(12):10475-9.
Orriss IR, Knight GE, Ranasinghe S, Burnstock G, Arnett TR. Osteoblast responses to nucleotides increase during differentiation.. Bone 2006 Aug;39(2):300-9.
Sömjen D, Kaye AM, Binderman I. Stimulation of creatine kinase BB activity by parathyroid hormone and by prostaglandin E2 in cultured bone cells.. Biochem J 1985 Feb 1;225(3):591-6.
Chang X, Zheng Y, Yang Q, Wang L, Pan J, Xia Y, Yan X, Han J. Carbonic anhydrase I (CA1) is involved in the process of bone formation and is susceptible to ankylosing spondylitis.. Arthritis Res Ther 2012 Jul 27;14(4):R176.
Hügle T, Kovacs H, Heijnen IA, Daikeler T, Baisch U, Hicks JM, Valderrabano V. Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy.. Clin Exp Rheumatol 2012 Mar-Apr;30(2):240-5.